Diclofenac sodium gel 1%
Sponsors
Novartis, Akorn, Inc., Mylan Pharmaceuticals Private Limited, Biologische Heilmittel Heel GmbH
Conditions
Ankle SprainMuscle SorenessOsteoarthritisOsteoarthritis, Knee
Phase 3
Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis
CompletedNCT00171652
Start: 2005-05-31End: 2005-10-31Target: 360Updated: 2006-10-11
A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness
CompletedNCT02271854
Start: 2014-10-31End: 2014-12-31Updated: 2016-04-05
Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1%
CompletedNCT02913521
Start: 2015-06-30End: 2016-06-30Updated: 2021-02-26
A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee
CompletedNCT03172780
Start: 2017-05-24End: 2017-12-05Updated: 2022-03-03
TRAUMED - a Clinical Trial in Acute Ankle Sprain
CompletedNCT06192420
Start: 2018-02-26End: 2021-03-25Updated: 2024-01-31